BI (Business Intelligence) is a set of processes, architectures, and technologies that convert raw data into meaningful information that drives profitable business actions. It is a suite of software and services to transform data into actionable intelligence and knowledge.
Cambridge Antibody Technology has been described as the ‘jewel in the crown’ of the UK biotech industry; it is certainly one of our region’s principal success stories. This company, originally known as CAT, was founded in 1989 to take advantage of phage display technology for the development of antibody therapeutics. Following worldwide success with the blockbuster anti-TNF antibody adalimumab (Humira™) it was acquired by AstraZeneca in 2006 and now forms part of that company’s biologics subsidiary.
When it comes to influencing prospective customers in the life science sector, outbound marketing approaches such as cold calling, banner ads and unsolicited emails are no longer delivering a return on investment like they used to. Poorly targeted and relatively expensive, these once tried-and-tested tactics are increasingly delivering disappointing results. As marketers, if we want to continue to engage with modern scientific audiences, it’s vital that we adapt to be successful.
Whatsapp, Youtube, Google Ads, Linkedin, Facebook, Instagram, Twitter, e-mail, Teams, Skype, Slack… it’s easy to feel the dread and anxiety when glancing at your phone on an afternoon! All these platforms have one thing in common: your attention!
Even scientific brands have now joined the incessant competition for your attention. So how do you separate the signal from the noise in this increasingly competitive world?